DOCK9 and neoplasm: The exosomal lncRNA DOCK9-AS2 enhances EMT and stemness in PTC by modulating the Wnt/β-catenin pathway while interacting with SP1/miR-1972 signaling to support an aggressive tumor phenotype [26].